The benefits of using computer-aided analysis in molecular pathology are of significant value to the process and reporting. New IHC targets, such as PD-L1, are becoming an imperative part in treating cancer.
The benefits of using computer-aided analysis in molecular pathology are of significant value to the process and reporting. New IHC targets, such as PD-L1, are becoming an imperative part in treating cancer.